MIRIXA Australia and Boehringer
Ingelheim have partnered to
release a new Mirixa program titled
‘Spiriva New to Therapy Program”.
A paid professional service, with
fees paid per patient session, the
program facilitates pharmacists to
initiate newly prescribed Spiriva
patients to the medicine and
HandiHaler device then follow up
with the patient a month later.
“It is a sign of the times that
pharmacists are being recognised
as the medicines experts with the
technology and clinical tools to
deliver systemised, quality patient
outcomes,” said Pharmacy Guild of
Australia national president, Kos
Sclavos.
Mirixa has said that it will be
shortly be contacting pharmacies
directly following the program’s
launch.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Aug 10
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.